NOS3, nitric oxide synthase 3, 4846

N. diseases: 706; N. variants: 39
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0035344
Disease: Retinopathy of Prematurity
Retinopathy of Prematurity
0.050 GeneticVariation disease BEFREE Haplotype reconstruction showed that haplotypes in VEGF and eNOS are significantly associated with different effects on RDS, BPD, IVH, and ROP in our population. 26172140 2015
CUI: C0035344
Disease: Retinopathy of Prematurity
Retinopathy of Prematurity
0.050 GeneticVariation disease BEFREE Interaction between NOS3 gene polymorphisms and the duration of oxygen therapy was also explored in ROP babies. 26823875 2015
CUI: C0035344
Disease: Retinopathy of Prematurity
Retinopathy of Prematurity
0.050 GeneticVariation disease BEFREE Endothelial nitric oxide synthase genotypes in the etiology of retinopathy of prematurity in premature infants. 20809776 2010
CUI: C0035344
Disease: Retinopathy of Prematurity
Retinopathy of Prematurity
0.050 GeneticVariation disease BEFREE Multiple logistic regression analysis revealed that male gender (p=0.046) and eNOS aa genotype (p=0.047 versus ab genotype and p=0.022 versus bb genotype) were significantly associated severe ROP that required treatment. 18334945 2008
CUI: C0035344
Disease: Retinopathy of Prematurity
Retinopathy of Prematurity
0.050 GeneticVariation disease LHGDN Multiple logistic regression analysis revealed that male gender (p=0.046) and eNOS aa genotype (p=0.047 versus ab genotype and p=0.022 versus bb genotype) were significantly associated severe ROP that required treatment. 18334945 2008
CUI: C0035344
Disease: Retinopathy of Prematurity
Retinopathy of Prematurity
0.050 GeneticVariation disease BEFREE Normal mice, mice treated with the nitric oxide synthase (NOS) inhibitor N:(G)-nitro-L-arginine (L-NNA), and knockout mice carrying a homozygous targeted disruption of the gene for endothelial NOS (eNOS) were studied in an experimental model of ROP. 11133872 2001